Protein Kinase Inhibitors: all 15,766 studies that test it

Page 142 of 158. Open to participants first (2,605), then studies with results posted, then the rest; newest registration first within each.

• Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line TreatmentCompletedNCT00840125Phase 2
• Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin TreatmentStatus unknownNCT00839111Phase 2
• Temsirolimus for Relapsed/Refractory Hodgkin's LymphomaTerminatedNCT00838955Phase 2
• A Study of BMS-863233 in Patients With Hematologic CancerTerminatedNCT00838890Phase 1/2
• Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental ChamberCompletedNCT00836914Phase 1
• 2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC)CompletedNCT00835471Phase 2
• Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 ExpressionCompletedNCT00835419Phase 2
• A Study of ARRY-334543 and Docetaxel in Patients With Advanced CancerCompletedNCT00833326Phase 1
• Efficacy of AB1010 in Patients With Systemic Indolent MastocytosisCompletedNCT00831974Phase 2
• Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid ArthritisCompletedNCT00831922Phase 2
• RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC)CompletedNCT00830895Phase 2
• A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung CancerTerminatedNCT00830245Phase 2
• A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic LeukemiaWithdrawnNCT00829647Phase 1/2
• Hepatic Impairment StudyCompletedNCT00829231Phase 1
• Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular CarcinomaTerminatedNCT00828594Phase 1
• Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant PatientsStatus unknownNCT00828503Phase 2
• Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)CompletedNCT00827138Phase 1
• An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00826878Phase 1
• Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib TreatmentCompletedNCT00825955Phase 3
• A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck CancerCompletedNCT00824343Phase 2
• Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC)TerminatedNCT00823290Phase 1
• Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant GliomasCompletedNCT00822887Phase 1
• Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue SarcomaCompletedNCT00822848Phase 1
• Vandetanib and Sirolimus in Patients With Recurrent GlioblastomaCompletedNCT00821080Phase 1
• A Study to Examine the Effects of Low and High-fat Meals on Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer PatientsCompletedNCT00821054Phase 1
• Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor CellsTerminatedNCT00820924Phase 2
• Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant RecipientsCompletedNCT00820911Phase 2
• RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDSActive, not recruitingNCT00819546Phase 1
• Activity Study of Sunitinib In Metastatic Pretreated Urothelial CancerStatus unknownNCT00818350Phase 1/2
• A Dose-Escalating Study of RO4987655 in Patients With Advanced Solid TumorsCompletedNCT00817518Phase 1
• Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT00816283Phase 1
• A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) ModelCompletedNCT00814944Phase 2
• ATAC - Endometrial Sub-ProtocolCompletedNCT00814125Phase 3
• Masitinib in Severe Indolent or Smoldering Systemic MastocytosisCompletedNCT00814073Phase 3
• Study Evaluating TwoTablet Formulations of Neratinib (HKI-272)CompletedNCT00814060Phase 1
• Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the BrainCompletedNCT00814021Phase 2
• Sunitinib Malate and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors That Have Not Responded to ChemotherapyCompletedNCT00813423Phase 1
• A Phase 1 Study of AMG 208 in Subjects With Advanced Solid TumorsCompletedNCT00813384Phase 1
• Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant PatientsCompletedNCT00812786Phase 4
• Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)TerminatedNCT00812240Phase 3
• Calcineurin Free Immunosuppression in Renal Transplant RecipientsCompletedNCT00812123Phase 4
• A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid TumorsTerminatedNCT00811993Phase 1
• Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney TransplantationTerminatedNCT00811915Phase 3
• Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV MelanomaStatus unknownNCT00811759Phase 1/2
• A Study of ARRY-371797 in Patients With Active Ankylosing SpondylitisTerminatedNCT00811499Phase 2
• Trial to Evaluate the Therapeutic Benefit of Fulvestrant in Combination With ZACTIMA in Postmenopausal Women With Bone Predominant, Hormone Receptor Positive Metastatic Breast CancerCompletedNCT00811369Phase 2
• Hydroxychloroquine and Gefitinib to Treat Lung CancerStatus unknownNCT00809237Phase 1/2
• Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00809211Phase 2
• Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous PolyposisCompletedNCT00808743Phase 2/3
• Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC)WithdrawnNCT00808145Phase 2
• Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid TumorsTerminatedNCT00807755Phase 1
• A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic MalignanciesCompletedNCT00807677Phase 1
• Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain MetastasesTerminatedNCT00807170Phase 1
• Randomized Gefitinib TrialCompletedNCT00807066Phase 3
• FOLFIRI and Sunitinib in Metastatic Colorectal CancerCompletedNCT00806663Phase 2
• Study of ENMD-2076 in Patients With Multiple MyelomaCompletedNCT00806065Phase 1
• Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsCompletedNCT00804336Phase 1
• Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC)CompletedNCT00802555Phase 1
• Efficacy of AM-111 in Patients With Acute Sensorineural Hearing LossCompletedNCT00802425Phase 2
• Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to ChemotherapyStatus unknownNCT00801385Phase 2
• A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal CancerCompletedNCT00801294Phase 2
• A Study of Temsirolimus and Bevacizumab in Recurrent Glioblastoma MultiformeCompletedNCT00800917Phase 2
• CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter TrialCompletedNCT00799188Phase 3
• SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED)TerminatedNCT00798213Phase 2
• Temsirolimus and Radiation for Non-Small Cell Lung CancerCompletedNCT00796796Phase 1
• Sorafenib in Previously Treated Malignant MesotheliomaStatus unknownNCT00794859Phase 2
• A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of E6201 in Subjects With Advanced Solid TumorsCompletedNCT00794781Phase 1
• Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and DacarbazineCompletedNCT00794235Phase 2
• Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid TumorsCompletedNCT00793897Phase 1
• The Efficacy and Safety of Curcuma Domestica Extracts and Ibuprofen in Knee OsteoarthritisCompletedNCT00792818Phase 3
• Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)CompletedNCT00792766Phase 1/2
• Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell CancerCompletedNCT00792025Phase 2
• Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver CarcinomaTerminatedNCT00791544Phase 1/2
• Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical ProstatectomyCompletedNCT00790595Phase 1
• Phase II Study of TKI258 in Advanced Urothelial CarcinomaCompletedNCT00790426Phase 2
• A Safety Study of ARRY-371797 in Healthy SubjectsCompletedNCT00790049Phase 1
• Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic CarcinomaCompletedNCT00789763Phase 1
• Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic CancerCompletedNCT00789633Phase 3
• Single and Multiple Dose Escalation Study of VX-509 in Healthy SubjectsCompletedNCT00789126Phase 1
• S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid TumorsWithdrawnNCT00788580Phase 1
• Combination Study of BMS-754807 and Herceptin® in Patients With Advanced or Metastatic Her-2-positive Breast CancerCompletedNCT00788333Phase 1/2
• Subretinal Macugen® for Neovascular Age-Related Macular DegenerationStatus unknownNCT00788177Phase 3
• Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or LymphomasCompletedNCT00788099Phase 1
• A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell CarcinomaCompletedNCT00788060Phase 1
• Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT00787969Phase 1
• An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant MesotheliomaCompletedNCT00787410Phase 2
• Efficacy of Imatinib Mesylate in Hypereosinophilic SyndromesCompletedNCT00787384Phase 2
• A Study Of PF-04554878 In Patients With Advanced Non-Hematologic MalignanciesCompletedNCT00787033Phase 1
• Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic PhaseCompletedNCT00786812Phase 4
• Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer PatientsStatus unknownNCT00786110Phase 2
• Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]CompletedNCT00785954Phase 2
• RDEA119 and Sorafenib Combination Dose Escalation StudyCompletedNCT00785226Phase 1/2
• ATAC - Bone Density Sub-ProtocolCompletedNCT00784940Phase 3
• A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain TumorsCompletedNCT00784914Phase 1
• ATAC - Pharmacokinetics (PK) Sub-ProtocolCompletedNCT00784862Phase 3
• ATAC - Quality of Life Sub-ProtocolCompletedNCT00784680Phase 3
• Dual Inhibition of EGFR Signalling Using the Combination of Cetuximab and ErlotinibStatus unknownNCT00784667Phase 2
• Phase I/II Study of TSU-68 for Advanced Hepatocellular CarcinomaCompletedNCT00784290Phase 1/2
• Clinical Study of SU 11248 (Sutent) Combined With Standard Chemotherapy in Patients With FLT3 Mutated AML Over 60 YearsCompletedNCT00783653Phase 1/2
• Docetaxel Intermittent-Erlotinib (Tarceva®) In Metastatic Non Small Cell Lung Cancer (NSCLC)TerminatedNCT00783471Phase 2

← Protein Kinase Inhibitors overview